Biologics Consulting Appoints Dr. Margaret K. Vernon As Its New Chief Executive Officer

ALEXANDRIA, Va. ~ Biologics Consulting Group, Inc. has appointed Dr. Margaret K. Vernon as their new Chief Executive Officer, effective September 18, 2023. Dr. Vernon joins Biologics Consulting Group after 17 years with Evidera, a business unit of PPD.

Dr. Norman W. Baylor, former President and CEO of Biologics Consulting, expressed his delight in welcoming Dr. Vernon to the management team: "Margaret is dynamic, creative, and results driven. She has a strong leadership background and a clear strategic vision for the firm."

Dr. Vernon holds a Ph.D in Developmental Psychology with a concentration in statistics and research methodology from The Pennsylvania State University, State College, PA and additional training in finance and accounting from the Wharton Executive Program. She is an expert regarding patient-reported outcome (PRO) instrument development and validation programs with a special interest in measurement in rare diseases; she also has expertise in regulatory strategy and PRO clinical trial implementation and analysis as well as considerable experience and formal training in both qualitative and quantitative methods.

More on
Commenting on her appointment as CEO of Biologics Consulting Group, Dr. Vernon said: "It is a pleasure to have been chosen as Biologics Consulting's new CEO...I very much look forward to leading the Biologics Consulting team as we use innovative approaches and multidisciplinary expertise to guide our clients through complex regulatory, scientific, and business challenges."

The selection of Dr. Vernon was made after an extensive national search conducted by the Biologic Consulting Board of Directors with the professional recruitment services of Odgers Berndtson. Dr. Baylor will remain as Chair of the Biologics Consulting Board of Directors while Dr. Vernon takes up her new role as CEO on September 18th 2023
Filed Under: Business

Show All News | Report Violation


Latest on